Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00697632
Title Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MethylGene Inc.
Indications

Advanced Solid Tumor

hematologic cancer

Therapies

Glesatinib

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.